Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 2

1.

Beck J, Greenwood DA, Blanton L et al (2017) 2017 national standards for diabetes self-management education and support. Diabetes Care 40:1409–1419. https://doi.org/10.2337/dci17-0025CrossRefPubMed

2.

Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or Prediabetes: a consensus report. Diabetes Care 42:731–754. https://doi.org/10.2337/dci19-0014CrossRefPubMedPubMedCentral

3.

(2019) Ausschuss Ernährung der DDG. Stellungnahme des Ausschuss Ernährung der DDG zum Consensus Report: Nutrition Therapy for Adults with Diabetes or Prediabetes: [Evert AB et al. Diabetes Care 2019;42:731–754. https://www.deutsche-diabetes-gesellschaft.de/politik/stellungnahmen/stellungnahme-des-ausschuss-ernaehrung-der-ddg-zum-consensus-report-nutrition-therapy-for-adults-with-diabetes-or-prediabetes

4.

DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368. https://doi.org/10.2337/diacare.15.3.318CrossRefPubMed

5.

DeFronzo RA, Eldor R, Abdul-Ghani M (2013) Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 36(Suppl. 02):S127–S138. https://doi.org/10.2337/dcS13-2011CrossRefPubMedPubMedCentral

6.

Lencioni C, Lupi R, Del Prato S (2008) Beta-cell failure in type 2 diabetes mellitus. Curr Diab Rep 8:179–184. https://doi.org/10.1007/s11892-008-0031-0CrossRefPubMed

7.

Anonymous. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44: 1249–1258

8.

Zaharia OP, Strassburger K, Strom A et al (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5‑year follow-up study. Lancet Diabetes Endocrinol 7:684–694. https://doi.org/10.1016/S2213-8587(19)30187-1CrossRefPubMed

9.

Kodama S, Horikawa C, Fujihara K et al (2014) Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis. Obes Rev 15:202–214. https://doi.org/10.1111/obr.12129CrossRefPubMed

10.

Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34:1481–1486. https://doi.org/10.2337/dc10-2415CrossRefPubMedPubMedCentral

11.

Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39:808–815. https://doi.org/10.2337/dc15-1942CrossRefPubMed

12.

Jazet IM, Pijl H, Frölich M et al (2005) Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients. Diabet Med 22:52–55. https://doi.org/10.1111/j.1464-5491.2004.01357.xCrossRefPubMed

13.

Lean MEJ, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391:541–551. https://doi.org/10.1016/S0140-6736(17)33102-1CrossRefPubMed

14.

Bangalore S, Fayyad R, DeMicco DA et al (2018) Body weight variability and cardiovascular outcomes in patients with type 2 diabetes mellitus. Circ Cardiovasc Qual Outcomes 11:e4724. https://doi.org/10.1161/CIRCOUTCOMES.118.004724CrossRefPubMed

15.

Yeboah P, Hsu FC, Bertoni AG et al (2019) Body mass index, change in weight, body weight variability and outcomes in type 2 diabetes mellitus (from the ACCORD trial). Am J Cardiol 123:576–581. https://doi.org/10.1016/j.amjcard.2018.11.016CrossRefPubMed

16.

Pagidipati NJ, Zheng Y, Green JB et al (2020) Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. Am Heart J 219:47–57. https://doi.org/10.1016/j.ahj.2019.09.016CrossRefPubMed

17.

Bodegard J, Sundström J, Svennblad B et al (2013) Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab 39:306–313. https://doi.org/10.1016/j.diabet.2013.05.004CrossRefPubMed

18.

Weinheimer EM, Sands LP, Campbell WW (2010) A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev 68:375–388. https://doi.org/10.1111/j.1753-4887.2010.00298.xCrossRefPubMed

19.

Zaccardi F, Dhalwani NN, Papamargaritis D et al (2017) Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414587 participants in prospective studies. Diabetologia 60:240–248. https://doi.org/10.1007/s00125-016-4162-6CrossRefPubMed

20.

Salehidoost R, Mansouri A, Amini M et al (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577. https://doi.org/10.1007/s00592-018-1126-yCrossRefPubMed

21.

Hainer V, Aldhoon-Hainerová I (2013) Obesity paradox does exist. Diabetes Care 36(Suppl. 02):S276–S281. https://doi.org/10.2337/dcS13-2023CrossRefPubMedPubMedCentral

22.

Murphy RA, Reinders I, Garcia ME et al (2014) Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care 37:3213–3219. https://doi.org/10.2337/dc14-0293CrossRefPubMedPubMedCentral

23.

Bales CW, Starr PKN (2018) Obesity interventions for older adults: diet as a determinant of physical function. Adv Nutr 9:151–159. https://doi.org/10.1093/advances/nmx016CrossRefPubMedPubMedCentral

24.

Uusitupa M, Khan TA, Viguiliouk E et al (2019) Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/nu11112611CrossRefPubMedPubMedCentral

25.

Raben A, Vestentoft PS, Brand-Miller J et al (2021) The PREVIEW intervention study: Results from a 3‑year randomized 2 × 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes. Diabetes Obes Metab 23:324–337. https://doi.org/10.1111/dom.14219CrossRefPubMed

26.

Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496. https://doi.org/10.1001/jama.2012.67929CrossRefPubMedPubMedCentral

27.

Anderson JW, Konz EC, Frederich RC et al (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74:579–584. https://doi.org/10.1093/ajcn/74.5.579CrossRefPubMed

28.

Bundesgesundheitsministerium (2015) Telemedizin. https://www.bundesgesundheitsministerium.de/service/begriffe-von-a-z/t/telemedizin.html. Zugegriffen: 9. Apr. 2021

29.

Su D, McBride C, Zhou J et al (2016) Does nutritional counseling in telemedicine improve treatment outcomes for diabetes? A systematic review and meta-analysis of results from 92 studies. J Telemed Telecare 22:333–347. https://doi.org/10.1177/1357633X15608297CrossRefPubMed

30.

Kempf K, Altpeter B, Berger J et al (2017) Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care 40:863–871. https://doi.org/10.2337/dc17-0303CrossRefPubMed

31.

Belalcazar LM, Haffner SM, Lang W et al (2013) Lifestyle intervention and/or statins for the reduction of C‑reactive protein in type 2 diabetes: from the look AHEAD study. Obesity 21:944–950. https://doi.org/10.1002/oby.20431CrossRefPubMed

32.

Colquitt JL, Pickett K, Loveman E et al (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003641.pub4CrossRefPubMedPubMedCentral

33.

Patel KV, Bahnson JL, Gaussoin SA et al (2020) Association of baseline and longitudinal changes in body composition measures with risk of heart failure and myocardial infarction in type 2 diabetes: findings from the look AHEAD trial. Circulation 142:2420–2430. https://doi.org/10.1161/CIRCULATIONAHA.120.050941CrossRefPubMedPubMedCentral

34.

Franz MJ, Boucher JL, Rutten-Ramos S et al (2015) Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115:1447–1463. https://doi.org/10.1016/j.jand.2015.02.031CrossRefPubMed

35.

Murgatroyd PR, Goldberg GR, Leahy FE et al (1999) Effects of inactivity and diet composition on human energy balance. Int J Obes Relat Metab Disord 23:1269–1275. https://doi.org/10.1038/sj.ijo.0801062CrossRefPubMed

36.

Stubbs RJ, Sepp A, Hughes DA et al (2002) The effect of graded levels of exercise on energy intake and balance in free-living women. Int J Obes Relat Metab Disord 26:866–869. https://doi.org/10.1038/sj.ijo.0801874CrossRefPubMed

37.

Granados K, Stephens BR, Malin SK et al (2012) Appetite regulation in response to sitting and energy imbalance. Appl Physiol Nutr Metab 37:323–333. https://doi.org/10.1139/h2012-002CrossRefPubMed

38.

Hägele FA, Büsing F, Nas A et al (2019) Appetite control is improved by acute increases in energy turnover at different levels of energy balance. J Clin Endocrinol Metab 104:4481–4491. https://doi.org/10.1210/jc.2019-01164CrossRefPubMed

39.

Douglas JA, King JA, Clayton DJ et al (2017) Acute effects of exercise on appetite, ad libitum energy intake and appetite-regulatory hormones in lean and overweight/obese men and women. Int J Obes 41:1737–1744. https://doi.org/10.1038/ijo.2017.181CrossRef

40.

Savikj M, Zierath JR (2020) Train like an athlete: applying exercise interventions to manage type 2 diabetes. Diabetologia 63:1491–1499. https://doi.org/10.1007/s00125-020-05166-9CrossRefPubMedPubMedCentral

41.

Büsing F, Hägele FA, Nas A et al (2019) Impact of energy turnover on the regulation of glucose homeostasis in healthy subjects. Nutr Diabetes 9:22. https://doi.org/10.1038/s41387-019-0089-6CrossRefPubMedPubMedCentral

42.

Larsen JJ, Dela F, Kjaer M et al (1997) The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 40:447–453. https://doi.org/10.1007/s001250050699CrossRefPubMed

43.

Heden TD, Winn NC, Mari A et al (2015) Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes. J Appl Physiol 118:624–634. https://doi.org/10.1152/japplphysiol.00917.2014CrossRefPubMed

44.

Reynolds AN, Mann JI, Williams S et al (2016) Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia 59:2572–2578. https://doi.org/10.1007/s00125-016-4085-2CrossRefPubMed

45.

Gaudet-Savard T, Ferland A, Broderick TL et al (2007) Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 14:831–836. https://doi.org/10.1097/HJR.0b013e3282efaf38CrossRefPubMed

46.

DiPietro L, Gribok A, Stevens MS et al (2013) Three 15-min bouts of moderate postmeal walking significantly improves 24‑h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care 36:3262–3268. https://doi.org/10.2337/dc13-0084CrossRefPubMedPubMedCentral

47.

Seidelmann SB, Claggett B, Cheng S et al (2018) Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health 3:e419–e428. https://doi.org/10.1016/S2468-2667(18)30135-XCrossRefPubMedPubMedCentral

48.

Davies MJ, D’Alessio DA, Fradkin J et al (2018) Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 41:2669–2701. https://doi.org/10.2337/dci18-0033CrossRefPubMedPubMedCentral

49.

Schwingshackl L, Chaimani A, Hoffmann G et al (2018) A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol 33:157–170. https://doi.org/10.1007/s10654-017-0352-xCrossRefPubMedPubMedCentral

50.

Schwingshackl L, Hoffmann G, Iqbal K et al (2018) Food groups and intermediate disease markers: a systematic review and network meta-analysis of randomized trials. Am J Clin Nutr 108:576–586. https://doi.org/10.1093/ajcn/nqy151CrossRefPubMedPubMedCentral

51.

Neuenschwander M, Ballon A, Weber KS et al (2019) Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366:l2368. https://doi.org/10.1136/bmj.l2368CrossRefPubMedPubMedCentral

52.

Ge L, Sadeghirad B, Ball GDC et al (2020) Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ 369:m696. https://doi.org/10.1136/bmj.m696CrossRefPubMedPubMedCentral

53.

Goldenberg JZ, Day A, Brinkworth GD et al (2021) Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 372:m4743. https://doi.org/10.1136/bmj.m4743CrossRefPubMedPubMedCentral

54.

Schwingshackl L, Nitschke K, Zähringer J et al (2020) Impact of meal frequency on anthropometric outcomes: a systematic review and network meta-analysis of randomized controlled trials. Adv Nutr 11:1108–1122. https://doi.org/10.1093/advances/nmaa056CrossRefPubMedPubMedCentral

55.

Della Corte KW, Perrar I, Penczynski KJ et al (2018) Effect of dietary sugar intake on biomarkers of subclinical inflammation: a systematic review and meta-analysis of intervention studies. Nutrients. https://doi.org/10.3390/nu10050606CrossRefPubMedPubMedCentral

56.

Schwingshackl L, Chaimani A, Schwedhelm C et al (2019) Comparative effects of different dietary approaches on blood pressure in hypertensive and pre-hypertensive patients: A systematic review and network meta-analysis. Crit Rev Food Sci Nutr 59:2674–2687. https://doi.org/10.1080/10408398.2018.1463967CrossRefPubMed

57.

Thom G, Messow CM, Leslie WS et al (2020) Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med. https://doi.org/10.1111/dme.14395CrossRefPubMed

58.

de Souza RJ, Mente A, Maroleanu A et al (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 351:h3978. https://doi.org/10.1136/bmj.h3978CrossRefPubMedPubMedCentral

59.

Astrup A, Magkos F, Bier DM et al (2020) Saturated fats and health: a reassessment and proposal for food-based recommendations: JACC state-of-the-art review. J Am Coll Cardiol 76:844–857. https://doi.org/10.1016/j.jacc.2020.05.077CrossRefPubMed

60.

Pimpin L, Wu JHY, Haskelberg H et al (2016) Is butter back? A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, and total mortality. PLoS ONE 11:e158118. https://doi.org/10.1371/journal.pone.0158118CrossRefPubMedPubMedCentral

61.

Benatar JR, Sidhu K, Stewart RAH (2013) Effects of high and low fat dairy food on cardio-metabolic risk factors: a meta-analysis of randomized studies. Plos One 8:e76480. https://doi.org/10.1371/journal.pone.0076480CrossRefPubMedPubMedCentral

62.

Hooper L, Abdelhamid AS, Jimoh OF et al (2020) Effects of total fat intake on body fatness in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013636CrossRefPubMedPubMedCentral

63.

Hooper L, Martin N, Jimoh OF et al (2020) Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011737.pub3CrossRefPubMedPubMedCentral

64.

Belalcazar LM, Reboussin DM, Haffner SM et al (2010) A 1‑year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C‑reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33:2297–2303. https://doi.org/10.2337/dc10-0728CrossRefPubMedPubMedCentral

65.

Lu M, Wan Y, Yang B et al (2018) Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr 119:96–108. https://doi.org/10.1017/S0007114517002902CrossRefPubMed

66.

Wu JHY, Marklund M, Imamura F et al (2017) Omega‑6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol 5:965–974. https://doi.org/10.1016/S2213-8587(17)30307-8CrossRefPubMedPubMedCentral

67.

Li J, Guasch-Ferré M, Li Y et al (2020) Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr 112:150–167. https://doi.org/10.1093/ajcn/nqz349CrossRefPubMedPubMedCentral

68.

Pan , Chen M, Chowdhury R et al (2012) α‑Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 96:1262–1273. https://doi.org/10.3945/ajcn.112.044040CrossRefPubMedPubMedCentral

69.

Abdelhamid AS, Martin N, Bridges C et al (2018) Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012345.pub3CrossRefPubMedPubMedCentral

70.

Abdelhamid AS, Brown TJ, Brainard JS et al (2020) Omega‑3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003177.pub5CrossRefPubMedPubMedCentral

71.

Brown TJ, Brainard J, Song F et al (2019) Omega‑3, omega‑6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ 366:l4697. https://doi.org/10.1136/bmj.l4697CrossRefPubMedPubMedCentral

72.

Qian F, Korat AA, Malik V et al (2016) Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39:1448–1457. https://doi.org/10.2337/dc16-0513CrossRefPubMedPubMedCentral

73.

Jovanovski E, de Castro Ruiz MA, Li D et al (2019) Effect of high-carbohydrate or high-monounsaturated fatty acid diets on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 77:19–31. https://doi.org/10.1093/nutrit/nuy040CrossRefPubMed

74.

Zhang YY, Liu W, Zhao TY et al (2017) Efficacy of omega‑3 polyunsaturated fatty acids supplementation in managing overweight and obesity: a meta-analysis of randomized clinical trials. J Nutr Health Aging 21:187–192. https://doi.org/10.1007/s12603-016-0755-5CrossRefPubMed

75.

Lin N, Shi JJ, Li YM et al (2016) What is the impact of n‑3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis 15:133. https://doi.org/10.1186/s12944-016-0303-7CrossRefPubMedPubMedCentral

76.

Reis CEG, Landim KC, Nunes ACS et al (2014) Safety in the hypertriglyceridemia treatment with N‑3 polyunsaturated fatty acids on glucose metabolism in subjects with type 2 diabetes mellitus. Nutr Hosp 31:570–576. https://doi.org/10.3305/nh.2015.31.2.7845CrossRefPubMed

77.

Gao L, Cao J, Mao Q et al (2013) Influence of omega‑3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 226:328–334. https://doi.org/10.1016/j.atherosclerosis.2012.10.056CrossRefPubMed

78.

He XX, Wu XL, Chen RP et al (2016) Effectiveness of omega‑3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLoS ONE 11:e162368. https://doi.org/10.1371/journal.pone.0162368CrossRefPubMedPubMedCentral

79.

Li N, Yue H, Jia M et al (2019) Effect of low-ratio n‑6/n‑3 PUFA on blood glucose: a meta-analysis. Food Funct 10:4557–4565. https://doi.org/10.1039/c9fo00323aCrossRefPubMed

80.

Wanders AJ, Blom WAM, Zock PL et al (2019) Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials. BMJ Open Diabetes Res Care 7:e585. https://doi.org/10.1136/bmjdrc-2018-000585CrossRefPubMedPubMedCentral

81.

Abbott KA, Burrows TL, Thota RN et al (2016) Do ω‑3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 104:1470–1484. https://doi.org/10.3945/ajcn.116.138172CrossRefPubMed

82.

Jovanovski E, Li D, Ho THV et al (2017) The effect of alpha-linolenic acid on glycemic control in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized controlled clinical trials. Medicine 96:e6531. https://doi.org/10.1097/MD.0000000000006531CrossRefPubMedPubMedCentral

83.

Faris MAI, Jahrami H, BaHammam A et al (2020) A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects. Diabetes Res Clin Pract 165:108226. https://doi.org/10.1016/j.diabres.2020.108226CrossRefPubMed

84.

Mirmiran P, Bahadoran Z, Gaeini Z et al (2019) Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: an updated meta-analysis. Nutr Metab Cardiovasc Dis 29:906–915. https://doi.org/10.1016/j.numecd.2019.05.056CrossRefPubMed

85.

Fernando HA, Zibellini J, Harris RA et al (2019) Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/nu11020478CrossRefPubMedPubMedCentral

86.

Horne BD, May HT, Anderson JL et al (2008) Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102:814–819. https://doi.org/10.1016/j.amjcard.2008.05.021CrossRefPubMedPubMedCentral

87.

Horne BD, Muhlestein JB, May HT et al (2012) Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 109:1558–1562. https://doi.org/10.1016/j.amjcard.2012.01.379CrossRefPubMed

88.

Schwingshackl L, Zähringer J, Nitschke K et al (2021) Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses. Crit Rev Food Sci Nutr 61:1293–1304. https://doi.org/10.1080/10408398.2020.1757616CrossRefPubMed

89.

Park J, Seo YG, Paek YJ et al (2020) Effect of alternate-day fasting on obesity and cardiometabolic risk: a systematic review and meta-analysis. Metabolism 111:154336. https://doi.org/10.1016/j.metabol.2020.154336CrossRefPubMed

90.

Harris L, Hamilton S, Azevedo LB et al (2018) Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep 16:507–547. https://doi.org/10.11124/JBISRIR-2016-003248CrossRefPubMed

91.

Seimon RV, Roekenes JA, Zibellini J et al (2015) Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Mol Cell Endocrinol 418(Pt 2):153–172. https://doi.org/10.1016/j.mce.2015.09.014CrossRefPubMed

92.

Horne BD, Muhlestein JB, Anderson JL (2015) Health effects of intermittent fasting: hormesis or harm? A systematic review. Am J Clin Nutr 102:464–470. https://doi.org/10.3945/ajcn.115.109553CrossRefPubMed

93.

Borgundvaag E, Mak J, Kramer CK (2021) Metabolic impact of intermittent fasting in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of Interventional studies. J Clin Endocrinol Metab 106:902–911. https://doi.org/10.1210/clinem/dgaa926CrossRefPubMed

94.

Parr EB, Devlin BL, Lim KHC et al (2020) Time-restricted eating as a nutrition strategy for individuals with type 2 diabetes: a feasibility study. Nutrients. https://doi.org/10.3390/nu12113228CrossRefPubMedPubMedCentral

95.

Carter S, Clifton PM, Keogh JB (2016) The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 122:106–112. https://doi.org/10.1016/j.diabres.2016.10.010CrossRefPubMed

96.

Carter S, Clifton PM, Keogh JB (2019) The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract 151:11–19. https://doi.org/10.1016/j.diabres.2019.03.022CrossRefPubMed

97.

Corley BT, Carroll RW, Hall RM et al (2018) Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med 35:588–594. https://doi.org/10.1111/dme.13595CrossRefPubMed

98.

Henry RR, Wiest-Kent TA, Scheaffer L et al (1986) Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 35:155–164. https://doi.org/10.2337/diab.35.2.155CrossRefPubMed

99.

Amatruda JM, Richeson JF, Welle SL et al (1988) The safety and efficacy of a controlled low-energy (‘very-low-calorie’) diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 148:873–877CrossRef

100.

Rotella CM, Cresci B, Mannucci E et al (1994) Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus. J Endocrinol Invest 17:171–179. https://doi.org/10.1007/BF03347709CrossRefPubMed

101.

Dhindsa P, Scott AR, Donnelly R (2003) Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med 20:319–324. https://doi.org/10.1046/j.1464-5491.2003.00937.xCrossRefPubMed

102.

Lean MEJ, Leslie WS, Barnes AC et al (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2‑year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 7:344–355. https://doi.org/10.1016/S2213-8587(19)30068-3CrossRefPubMed

103.

Maggio CA, Pi-Sunyer FX (2003) Obesity and type 2 diabetes. Endocrinol Metab Clin North Am 32:805–822. https://doi.org/10.1016/s0889-8529(03)00071-9CrossRefPubMed

104.

Wolf AM, Colditz GA (1998) Current estimates of the economic cost of obesity in the United States. Obes Res 6:97–106. https://doi.org/10.1002/j.1550-8528.1998.tb00322.xCrossRefPubMed

105.

Colditz GA, Willett WC, Rotnitzky A et al (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486. https://doi.org/10.7326/0003-4819-122-7-199504010-00001CrossRefPubMed

106.

Anderson JW, Kendall CWC, Jenkins DJA (2003) Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 22:331–339. https://doi.org/10.1080/07315724.2003.10719316CrossRefPubMed

107.

Leslie WS, Taylor R, Harris L et al (2017) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes 41:96–101. https://doi.org/10.1038/ijo.2016.175CrossRef

108.

McCombie L, Brosnahan N, Ross H et al (2019) Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity. J Hum Nutr Diet 32:329–337. https://doi.org/10.1111/jhn.12611CrossRefPubMed

109.

Jazet IM, de Craen AJ, van Schie EM et al (2007) Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res Clin Pract 77:70–76. https://doi.org/10.1016/j.diabres.2006.10.019CrossRefPubMed

110.

Kempf K, Schloot NC, Gärtner B et al (2014) Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with 100 U insulin per day. J Hum Nutr Diet 27(Suppl. 02):21–27. https://doi.org/10.1111/jhn.12145CrossRefPubMed

111.

Kempf K, Röhling M, Niedermeier K et al (2018) Individualized meal replacement therapy improves clinically relevant long-term glycemic control in poorly controlled type 2 diabetes patients. Nutrients. https://doi.org/10.3390/nu10081022CrossRefPubMedPubMedCentral

112.

Taylor R, Leslie WS, Barnes AC et al (2018) Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort. Diabetologia 61:589–598. https://doi.org/10.1007/s00125-017-4503-0CrossRefPubMed

113.

Halle M, Röhling M, Banzer W et al (2021) Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial. Eur J Clin Nutr 75:661–669. https://doi.org/10.1038/s41430-020-00783-4CrossRefPubMed

114.

Röhling M, Kempf K, Banzer W et al (2020) Prediabetes conversion to normoglycemia is superior adding a low-carbohydrate and energy deficit formula diet to lifestyle intervention—A 12-month subanalysis of the ACOORH trial. Nutrients. https://doi.org/10.3390/nu12072022CrossRefPubMedPubMedCentral

115.

Holman RR, Paul SK, Bethel MA et al (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589. https://doi.org/10.1056/NEJMoa0806470CrossRefPubMed

116.

Haslacher H, Fallmann H, Waldhäusl C et al (2019) Type 2 diabetes care: Improvement by standardization at a diabetes rehabilitation clinic. An observational report. PLoS ONE 14:e226132. https://doi.org/10.1371/journal.pone.0226132CrossRefPubMedPubMedCentral

117.

Paul SK, Shaw JE, Montvida O et al (2016) Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes. Diabetes Obes Metab 18:1244–1252. https://doi.org/10.1111/dom.12761CrossRefPubMed

118.

[Anonymous]. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020. Diabetes care 2020; 43: S48–S65 https://doi.org/10.2337/dc20-S005.

119.

Dyson PA, Twenefour D, Breen C et al (2018) Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 35:541–547. https://doi.org/10.1111/dme.13603CrossRefPubMed

120.

Dworatzek PD, Arcudi K, Gougeon R et al (2013) Nutrition therapy. Can J Diabetes 37(Suppl. 01):S45–S55. https://doi.org/10.1016/j.jcjd.2013.01.019CrossRefPubMed

121.

Hallberg SJ, Dockter NE, Kushner JA et al (2019) Improving the scientific rigour of nutritional recommendations for adults with type 2 diabetes: a comprehensive review of the American diabetes association guideline-recommended eating patterns. Diabetes Obes Metab 21:1769–1779. https://doi.org/10.1111/dom.13736CrossRefPubMedPubMedCentral

122.

Salas-Salvadó J, Becerra-Tomás N, Papandreou C et al (2019) Dietary patterns emphasizing the consumption of plant foods in the management of type 2 diabetes: a narrative review. Adv Nutr 10:S320–S331. https://doi.org/10.1093/advances/nmy102CrossRefPubMedPubMedCentral

123.

Viguiliouk E, Kendall CW, Kahleová H et al (2019) Effect of vegetarian dietary patterns on cardiometabolic risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 38:1133–1145. https://doi.org/10.1016/j.clnu.2018.05.032CrossRefPubMed

124.

Papamichou D, Panagiotakos DB, Itsiopoulos C (2019) Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis 29:531–543. https://doi.org/10.1016/j.numecd.2019.02.004CrossRefPubMed

125.

Ohlsson B (2019) An Okinawan-based Nordic diet improves glucose and lipid metabolism in health and type 2 diabetes, in alignment with changes in the endocrine profile, whereas zonulin levels are elevated. Exp Ther Med 17:2883–2893. https://doi.org/10.3892/etm.2019.7303CrossRefPubMedPubMedCentral

126.

Daneshzad E, Emami S, Darooghegi Mofrad M et al (2018) Association of modified Nordic diet with cardiovascular risk factors among type 2 diabetes patients: a cross-sectional study. J Cardiovasc Thorac Res 10:153–161. https://doi.org/10.15171/jcvtr.2018.25CrossRefPubMedPubMedCentral

127.

Via MA, Mechanick JI (2016) Nutrition in type 2 diabetes and the metabolic syndrome. Med Clin North Am 100:1285–1302. https://doi.org/10.1016/j.mcna.2016.06.009CrossRefPubMed

128.

Porrata-Maury C, Hernández-Triana M, Ruiz-Álvarez V et al (2014) Ma-Pi 2 macrobiotic diet and type 2 diabetes mellitus: pooled analysis of short-term intervention studies. Diabetes Metab Res Rev 30(Suppl. 01):55–66. https://doi.org/10.1002/dmrr.2519CrossRefPubMed

129.

Garvey WT, Mechanick JI, Brett EM et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive CLINICAL Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 22(Suppl. 03):1–203. https://doi.org/10.4158/EP161365.GLCrossRefPubMed

130.

Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97:505–516. https://doi.org/10.3945/ajcn.112.042457CrossRefPubMed

131.

Huo R, Du T, Xu Y et al (2015) Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr 69:1200–1208. https://doi.org/10.1038/ejcn.2014.243CrossRefPubMed

132.

Pan B, Wu Y, Yang Q et al (2019) The impact of major dietary patterns on glycemic control, cardiovascular risk factors, and weight loss in patients with type 2 diabetes: A network meta-analysis. J Evid Based Med 12:29–39. https://doi.org/10.1111/jebm.12312CrossRefPubMed

133.

Johannesen CO, Dale HF, Jensen C et al (2020) Effects of plant-based diets on outcomes related to glucose metabolism: a systematic review. Diabetes Metab Syndr Obes 13:2811–2822. https://doi.org/10.2147/DMSO.S265982CrossRefPubMedPubMedCentral

134.

Toumpanakis A, Turnbull T, Alba-Barba I (2018) Effectiveness of plant-based diets in promoting well-being in the management of type 2 diabetes: a systematic review. BMJ Open Diabetes Res Care 6:e534. https://doi.org/10.1136/bmjdrc-2018-000534CrossRefPubMedPubMedCentral

135.

Tran E, Dale HF, Jensen C et al (2020) Effects of plant-based diets on weight status: a systematic review. Diabetes Metab Syndr Obes 13:3433–3448. https://doi.org/10.2147/DMSO.S272802CrossRefPubMedPubMedCentral

136.

Medawar E, Huhn S, Villringer A et al (2019) The effects of plant-based diets on the body and the brain: a systematic review. Transl Psychiatry 9:226. https://doi.org/10.1038/s41398-019-0552-0CrossRefPubMedPubMedCentral

137.

Esposito K, Maiorino MI, Bellastella G et al (2015) A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. Bmj Open 5:e8222. https://doi.org/10.1136/bmjopen-2015-008222CrossRefPubMedPubMedCentral

138.

Carter P, Achana F, Troughton J et al (2014) A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis. J Hum Nutr Diet 27:280–297. https://doi.org/10.1111/jhn.12138CrossRefPubMed

139.

Emadian A, Andrews RC, England CY et al (2015) The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. Br J Nutr 114:1656–1666. https://doi.org/10.1017/S0007114515003475CrossRefPubMedPubMedCentral

140.

Kahleova H, Salas-Salvadó J, Rahelić D et al (2019) Dietary patterns and cardiometabolic outcomes in diabetes: a summary of systematic reviews and meta-analyses. Nutrients. https://doi.org/10.3390/nu11092209CrossRefPubMedPubMedCentral

141.

DDG https://www.deutsche-diabetes-gesellschaft.de/fileadmin/user_upload/01_Die_DDG/03_Ausschuesse/02_Ernaehrung/2015-057-025l_S3_Diabetes_mellitus_Empfehlungen_Proteinzufuhr_2015-10.pdf; (Erstellt: 6. Juli 2021)

142.

Pfeiffer AFH, Pedersen E, Schwab U et al (2020) The effects of different quantities and qualities of protein intake in people with diabetes mellitus. Nutrients. https://doi.org/10.3390/nu12020365CrossRefPubMedPubMedCentral

143.

Mittendorfer B, Klein S, Fontana L (2020) A word of caution against excessive protein intake. Nat Rev Endocrinol 16:59–66. https://doi.org/10.1038/s41574-019-0274-7CrossRefPubMed

144.

Labonte CC, Chevalier S, Marliss EB et al (2015) Effect of 10% dietary protein intake on whole body protein kinetics in type 2 diabetic adults. Clin Nutr 34:1115–1121. https://doi.org/10.1016/j.clnu.2014.12.022CrossRefPubMed

145.

Markova M, Hornemann S, Sucher S et al (2018) Rate of appearance of amino acids after a meal regulates insulin and glucagon secretion in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 108:279–291. https://doi.org/10.1093/ajcn/nqy100CrossRefPubMed

146.

Volkert D (2020) Aktuelle ESPEN-Leitlinie Klinische Ernährung und Hydration in der Geriatrie. Dtsch Med Wochenschr 145:1306–1314. https://doi.org/10.1055/a-0986-2892CrossRefPubMed

147.

Song M, Fung TT, Hu FB et al (2016) Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med 176:1453–1463. https://doi.org/10.1001/jamainternmed.2016.4182CrossRefPubMedPubMedCentral

148.

Ye J, Yu Q, Mai W et al (2019) Dietary protein intake and subsequent risk of type 2 diabetes: a dose-response meta-analysis of prospective cohort studies. Acta Diabetol 56:851–870. https://doi.org/10.1007/s00592-019-01320-xCrossRefPubMed

149.

Vernooij RWM, Zeraatkar D, Han MA et al (2019) Patterns of red and processed meat consumption and risk for cardiometabolic and cancer outcomes: a systematic review and meta-analysis of cohort studies. Ann Intern Med 171:732–741. https://doi.org/10.7326/M19-1583CrossRefPubMed

150.

Vogtschmidt YD, Raben A, Faber I et al (2021) Is protein the forgotten ingredient: effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2021.05.011CrossRefPubMed

151.

Clifton PM, Condo D, Keogh JB (2014) Long term weight maintenance after advice to consume low carbohydrate, higher protein diets—a systematic review and meta analysis. Nutr Metab Cardiovasc Dis 24:224–235. https://doi.org/10.1016/j.numecd.2013.11.006CrossRefPubMed

152.

Hahn D, Hodson EM, Fouque D (2020) Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001892.pub5CrossRefPubMedPubMedCentral

153.

Ikizler TA, Burrowes JD, Byham-Gray LD et al (2020) KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis 76:S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006CrossRefPubMed

154.

Menon V, Kopple JD, Wang X et al (2009) Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53:208–217. https://doi.org/10.1053/j.ajkd.2008.08.009CrossRefPubMed

155.

Jiang Z (2017) Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. https://doi.org/10.1007/s11255-017-1713-9CrossRefPubMed

156.

Fiaccadori E, Sabatino A, Barazzoni R et al (2021) ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease. Clin Nutr 40:1644–1668. https://doi.org/10.1016/j.clnu.2021.01.028CrossRefPubMed

157.

Dong JY, Zhang ZL, Wang PY et al (2013) Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Br J Nutr 110:781–789. https://doi.org/10.1017/S0007114513002055CrossRefPubMed

158.

[Anonymous]. Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food Nutr Pap 1998; 66: 1–140

159.

Wolever TMS (2016) Personalized nutrition by prediction of glycaemic responses: fact or fantasy? Eur J Clin Nutr 70:411–413. https://doi.org/10.1038/ejcn.2016.31CrossRefPubMed

160.

Berry SE, Valdes AM, Drew DA et al (2020) Human postprandial responses to food and potential for precision nutrition. Nat Med 26:964–973. https://doi.org/10.1038/s41591-020-0934-0CrossRefPubMedPubMedCentral

161.

Zeevi D, Korem T, Zmora N et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094. https://doi.org/10.1016/j.cell.2015.11.001CrossRefPubMed

162.

Jung CH, Choi KM (2017) Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes. Nutrients. https://doi.org/10.3390/nu9040322CrossRefPubMedPubMedCentral

163.

Livesey G, Taylor R, Livesey H et al (2013) Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies. Am J Clin Nutr 97:584–596. https://doi.org/10.3945/ajcn.112.041467CrossRefPubMedPubMedCentral

164.

Livesey G, Livesey H (2019) Coronary heart disease and dietary carbohydrate, glycemic index, and glycemic load: dose-response meta-analyses of prospective cohort studies. Mayo Clin Proc Innov Qual Outcomes 3:52–69. https://doi.org/10.1016/j.mayocpiqo.2018.12.007CrossRefPubMedPubMedCentral

165.

Thomas DE, Elliott EJ (2010) The use of low-glycaemic index diets in diabetes control. Br J Nutr 104:797–802. https://doi.org/10.1017/S0007114510001534CrossRefPubMed

166.

Xu B, Fu J, Qiao Y et al (2021) Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with type 2 diabetes. Am J Clin Nutr. https://doi.org/10.1093/ajcn/nqaa435CrossRefPubMedPubMedCentral

167.

Jenkins DJA, Kendall CWC, McKeown-Eyssen G et al (2008) Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 300:2742–2753. https://doi.org/10.1001/jama.2008.808CrossRefPubMed

168.

Holub I, Gostner A, Hessdörfer S et al (2009) Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus. Horm Metab Res 41:886–892. https://doi.org/10.1055/s-0029-1234107CrossRefPubMed

169.

Brand-Miller J, Hayne S, Petocz P et al (2003) Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 26:2261–2267. https://doi.org/10.2337/diacare.26.8.2261CrossRefPubMed

170.

Ojo O, Ojo OO, Adebowale F et al (2018) The effect of dietary glycaemic index on glycaemia in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients. https://doi.org/10.3390/nu10030373CrossRefPubMedPubMedCentral

171.

Franz MJ, MacLeod J, Evert A et al (2017) Academy of nutrition and dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet 117:1659–1679. https://doi.org/10.1016/j.jand.2017.03.022CrossRefPubMed

172.

Vega-López S, Venn BJ, Slavin JL (2018) Relevance of the glycemic index and glycemic load for body weight, diabetes, and cardiovascular disease. Nutrients. https://doi.org/10.3390/nu10101361CrossRefPubMedPubMedCentral

173.

Jenkins DJA, Dehghan M, Mente A et al (2021) Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med 384:1312–1322. https://doi.org/10.1056/NEJMoa2007123CrossRefPubMed

174.

Coutinho M, Gerstein HC, Wang Y et al (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95783 individuals followed for 12.4 years. Diabetes Care 22:233–240. https://doi.org/10.2337/diacare.22.2.233CrossRefPubMed

175.

Levitan EB, Song Y, Ford ES et al (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155. https://doi.org/10.1001/archinte.164.19.2147CrossRefPubMed

176.

Siri PW, Krauss RM (2005) Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 7:455–459. https://doi.org/10.1007/s11883-005-0062-9CrossRefPubMed

177.

Aune D, Norat T, Romundstad P et al (2013) Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol 28:845–858. https://doi.org/10.1007/s10654-013-9852-5CrossRefPubMed

178.

[Anonymous]. Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia 2015; 58: 1394–1408 https://doi.org/10.1007/s00125-015-3585-9.

179.

Kim Y, Je Y (2016) Dietary fibre intake and mortality from cardiovascular disease and all cancers: A meta-analysis of prospective cohort studies. Arch Cardiovasc Dis 109:39–54. https://doi.org/10.1016/j.acvd.2015.09.005CrossRefPubMed

180.

Reynolds AN, Akerman AP, Mann J (2020) Dietary fibre and whole grains in diabetes management: systematic review and meta-analyses. PLoS Med 17:e1003053. https://doi.org/10.1371/journal.pmed.1003053CrossRefPubMedPubMedCentral

181.

Da Silva Borges D, Fernandes R, Thives Mello A et al (2020) Prebiotics may reduce serum concentrations of C‑reactive protein and ghrelin in overweight and obese adults: a systematic review and meta-analysis. Nutr Rev 78:235–248. https://doi.org/10.1093/nutrit/nuz045CrossRefPubMed

182.

Reynolds A, Mann J, Cummings J et al (2019) Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393:434–445. https://doi.org/10.1016/S0140-6736(18)31809-9CrossRefPubMed

183.

Musa-Veloso K, Poon T, Harkness LS et al (2018) The effects of whole-grain compared with refined wheat, rice, and rye on the postprandial blood glucose response: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 108:759–774. https://doi.org/10.1093/ajcn/nqy112CrossRefPubMed

184.

Wang W, Li J, Chen X et al (2020) Whole grain food diet slightly reduces cardiovascular risks in obese/overweight adults: a systematic review and meta-analysis. BMC Cardiovasc Disord 20:82. https://doi.org/10.1186/s12872-020-01337-zCrossRefPubMedPubMedCentral

185.

Weickert MO, Roden M, Isken F et al (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94:459–471. https://doi.org/10.3945/ajcn.110.004374CrossRefPubMed

186.

Honsek C, Kabisch S, Kemper M et al (2018) Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT). Diabetologia 61:1295–1305. https://doi.org/10.1007/s00125-018-4582-6CrossRefPubMed

187.

Kabisch S, Meyer NMT, Honsek C et al (2019) Fasting glucose state determines metabolic response to supplementation with insoluble cereal fibre: a secondary analysis of the optimal fibre trial (OptiFiT). Nutrients. https://doi.org/10.3390/nu11102385CrossRefPubMedPubMedCentral

188.

Hjorth MF, Ritz C, Blaak EE et al (2017) Pretreatment fasting plasma glucose and insulin modify dietary weight loss success: results from 3 randomized clinical trials. Am J Clin Nutr 106:499–505. https://doi.org/10.3945/ajcn.117.155200CrossRefPubMed

189.

Xiao Z, Chen H, Zhang Y et al (2020) The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res 34:1237–1247. https://doi.org/10.1002/ptr.6609CrossRefPubMed

190.

Wang L, Yang H, Huang H et al (2019) Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials. J Transl Med 17:410. https://doi.org/10.1186/s12967-019-02159-0CrossRefPubMedPubMedCentral

191.

Rao M, Gao C, Xu L et al (2019) Effect of Inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis. J Diabetes Res 2019:5101423. https://doi.org/10.1155/2019/5101423CrossRefPubMedPubMedCentral

192.

Darooghegi Mofrad M, Mozaffari H, Mousavi SM et al (2020) The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: A systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 60:859–872. https://doi.org/10.1080/10408398.2018.1553140CrossRefPubMed

193.

Rahmani J, Miri A, Černevičiūtė R et al (2019) Effects of cereal beta-glucan consumption on body weight, body mass index, waist circumference and total energy intake: A meta-analysis of randomized controlled trials. Complement Ther Med 43:131–139. https://doi.org/10.1016/j.ctim.2019.01.018CrossRefPubMed

194.

Ho HVT, Sievenpiper JL, Zurbau A et al (2016) The effect of oat β‑glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 116:1369–1382. https://doi.org/10.1017/S000711451600341XCrossRefPubMed

195.

Jovanovski E, Yashpal S, Komishon A et al (2018) Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 108:922–932. https://doi.org/10.1093/ajcn/nqy115CrossRefPubMed

196.

Brum J, Ramsey D, McRorie J et al (2018) meta-analysis of usefulness of psyllium fiber as adjuvant antilipid therapy to enhance cholesterol lowering efficacy of Statins. Am J Cardiol 122:1169–1174. https://doi.org/10.1016/j.amjcard.2018.06.040CrossRefPubMed

197.

Ho HVT, Jovanovski E, Zurbau A et al (2017) A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B. Am J Clin Nutr 105:1239–1247. https://doi.org/10.3945/ajcn.116.142158CrossRefPubMed

198.

Pittler MH, Ernst E (2001) Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 110:724–730. https://doi.org/10.1016/s0002-9343(01)00702-1CrossRefPubMed

199.

Khan K, Jovanovski E, Ho HVT et al (2018) The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 28:3–13. https://doi.org/10.1016/j.numecd.2017.09.007CrossRefPubMed

200.

Thinggaard M, Jacobsen R, Jeune B et al (2010) Is the relationship between BMI and mortality increasingly U‑shaped with advancing age? A 10-year follow-up of persons aged 70–95 years. J Gerontol A Biol Sci Med Sci 65:526–531. https://doi.org/10.1093/gerona/glp214CrossRefPubMed

201.

Guigoz Y, Vellas B (1997) Malnutrition in the elderly: the Mini Nutritional Assessment (MNA). Ther Umsch 54:345–350PubMed

202.

Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 56:M366–M372. https://doi.org/10.1093/gerona/56.6.m366CrossRefPubMed

203.

[Anonym]. S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. 2. Auflage 2018 – AWMF-Register-Nr. 057-017. Diabetologie und Stoffwechsel 2018; 13: 423–489 https://doi.org/10.1055/a-0666-0820.

204.

Volkert D, Bauer J, Frühwald T et al (2013) S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGG Klinische Ernährung in der Geriatrie. Aktuel Ernahrungsmed 38:e1–e48CrossRef

205.

Zeyfang A, Wernecke J, Bahrmann A (2020) Diabetes mellitus im Alter. Diabetologie 15:S112–S119CrossRef

206.

Şat S, Aydınkoç-Tuzcu K, Berger F et al (2019) Diabetes und Migration. Diabetol Stoffwechs 14:S306–S317. https://doi.org/10.1055/a-0899-2742CrossRef

207.

Diker O, Deniz T, Çetinkaya A (2016) History of Turkish cuisine culture and the influence of the balkans. Int J Humanit Soc Sci 10:1–6

208.

Schmid B (2003) Ernährung und Migration. Utz, München (Zugl.: München, Techn. Univ., Diss., 2003)

209.

Magni P, Bier DM, Pecorelli S et al (2017) Perspective: improving nutritional guidelines for sustainable health policies: current status and perspectives. Adv Nutr 8:532–545. https://doi.org/10.3945/an.116.014738CrossRefPubMedPubMedCentral

210.

Praxistool zur Ernährung. Orientierungshilfe für die Diabetesberatung nach geografischen Räumen. https://migration.deutsche-diabetes-gesellschaft.de/fileadmin/user_upload/01_Die_DDG/05_Arbeitsgemeinschaften/AG_Migranten/Microsite/200417_Ernaehrungstoo_DDG-GB19-Einleger_04.pdf (Erstellt: 15. Juli 2021)

211.

European Commission Health promotion and disease prevention knowledge gateway: sugars and sweeteners. https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/sugars-sweeteners. Zugegriffen: 27. Jan. 2021

212.

Committee on Nutrition Carbohydrates and Health report, 2015. https://www.gov.uk/government/publications/ (Erstellt: 26. Jan. 2021)

213.

McKeown NM, Dashti HS, Ma J et al (2018) Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. Diabetologia 61:317–330. https://doi.org/10.1007/s00125-017-4475-0CrossRefPubMed

214.

Evans RA, Frese M, Romero J et al (2017) Chronic fructose substitution for glucose or sucrose in food or beverages has little effect on fasting blood glucose, insulin, or triglycerides: a systematic review and meta-analysis. Am J Clin Nutr 106:519–529. https://doi.org/10.3945/ajcn.116.145169CrossRefPubMed

215.

Evans RA, Frese M, Romero J et al (2017) Fructose replacement of glucose or sucrose in food or beverages lowers postprandial glucose and insulin without raising triglycerides: a systematic review and meta-analysis. Am J Clin Nutr 106:506–518. https://doi.org/10.3945/ajcn.116.145151CrossRefPubMed

216.

Keller A, Heitmann BL, Olsen N (2015) Sugar-sweetened beverages, vascular risk factors and events: a systematic literature review. Public Health Nutr 18:1145–1154. https://doi.org/10.1017/S1368980014002122CrossRefPubMed

217.

Huang C, Huang J, Tian Y et al (2014) Sugar sweetened beverages consumption and risk of coronary heart disease: a meta-analysis of prospective studies. Atherosclerosis 234:11–16. https://doi.org/10.1016/j.atherosclerosis.2014.01.037CrossRefPubMed

218.

Narain A, Kwok CS, Mamas MA (2016) Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract 70:791–805. https://doi.org/10.1111/ijcp.12841CrossRefPubMed

219.

Cheungpasitporn W, Thongprayoon C, O’Corragain OA et al (2014) Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology 19:791–797. https://doi.org/10.1111/nep.12343CrossRefPubMed

220.

Chen H, Wang J, Li Z et al (2019) Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty liver disease: an updated systematic review and dose-response meta-analysis. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph16122192CrossRefPubMedPubMedCentral

221.

Asgari-Taee F, Zerafati-Shoae N, Dehghani M et al (2019) Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr 58:1759–1769. https://doi.org/10.1007/s00394-018-1711-4CrossRefPubMed

222.

Khan TA, Sievenpiper JL (2016) Controversies about sugars: results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes. Eur J Nutr 55:25–43. https://doi.org/10.1007/s00394-016-1345-3CrossRefPubMedPubMedCentral

223.

Choo VL, Viguiliouk E, Blanco Mejia S et al (2018) Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies. BMJ 363:k4644. https://doi.org/10.1136/bmj.k4644CrossRefPubMedPubMedCentral

224.

Semnani-Azad Z, Khan TA, Blanco Mejia S et al (2020) Association of major food sources of fructose-containing sugars with incident metabolic syndrome: a systematic review and meta-analysis. JAMA Netw Open 3:e209993. https://doi.org/10.1001/jamanetworkopen.2020.9993CrossRefPubMedPubMedCentral

225.

Bechthold A (2018) Vollwertig essen und trinken nach den 10 Regeln der DGE. Deutsche Gesellschaft für Ernährung e. V. (DGE), Bonn

226.

Wu H, Flint AJ, Qi Q et al (2015) Association between dietary whole grain intake and risk of mortality: two large prospective studies in US men and women. JAMA Intern Med 175:373–384. https://doi.org/10.1001/jamainternmed.2014.6283CrossRefPubMedPubMedCentral

227.

Johnsen NF, Frederiksen K, Christensen J et al (2015) Whole-grain products and whole-grain types are associated with lower all-cause and cause-specific mortality in the Scandinavian HELGA cohort. Br J Nutr 114:608–623. https://doi.org/10.1017/S0007114515001701CrossRefPubMed

228.

Wei H, Gao Z, Liang R et al (2016) Whole-grain consumption and the risk of all-cause, CVD and cancer mortality: a meta-analysis of prospective cohort studies—CORRIGENDUM. Br J Nutr 116:952. https://doi.org/10.1017/S0007114516002543CrossRefPubMed

229.

Chen GC, Tong X, Xu JY et al (2016) Whole-grain intake and total, cardiovascular, and cancer mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 104:164–172. https://doi.org/10.3945/ajcn.115.122432CrossRefPubMed

230.

Benisi-Kohansal S, Saneei P, Salehi-Marzijarani M et al (2016) Whole-grain intake and mortality from all causes, cardiovascular disease, and cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Adv Nutr 7:1052–1065. https://doi.org/10.3945/an.115.011635CrossRefPubMedPubMedCentral

231.

Zong G, Gao A, Hu FB et al (2016) Whole grain intake and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Circulation 133:2370–2380. https://doi.org/10.1161/CIRCULATIONAHA.115.021101CrossRefPubMedPubMedCentral

232.

Aune D, Keum N, Giovannucci E et al (2016) Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ 353:i2716. https://doi.org/10.1136/bmj.i2716CrossRefPubMedPubMedCentral

233.

Aune D (2019) Plant foods, antioxidant biomarkers, and the risk of cardiovascular disease, cancer, and mortality: a review of the evidence. Adv Nutr 10:S404–S421. https://doi.org/10.1093/advances/nmz042CrossRefPubMedPubMedCentral

234.

Zhang B, Zhao Q, Guo W et al (2018) Association of whole grain intake with all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis from prospective cohort studies. Eur J Clin Nutr 72:57–65. https://doi.org/10.1038/ejcn.2017.149CrossRefPubMed

235.

Jenkins DJ, Wesson V, Wolever TM et al (1988) Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. BMJ 297:958–960. https://doi.org/10.1136/bmj.297.6654.958CrossRefPubMedPubMedCentral

236.

Reynolds AN, Mann J, Elbalshy M et al (2020) Wholegrain particle size influences postprandial glycemia in type 2 diabetes: a randomized crossover study comparing four Wholegrain breads. Diabetes Care 43:476–479. https://doi.org/10.2337/dc19-1466CrossRefPubMed

237.

Åberg S, Mann J, Neumann S et al (2020) Whole-grain processing and glycemic control in type 2 diabetes: a randomized crossover trial. Diabetes Care 43:1717–1723. https://doi.org/10.2337/dc20-0263CrossRefPubMedPubMedCentral

238.

Jenkins DJA, Kendall CWC, Augustin LSA et al (2002) Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 25:1522–1528. https://doi.org/10.2337/diacare.25.9.1522CrossRefPubMed

239.

Miller V, Mente A, Dehghan M et al (2017) Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet 390:2037–2049. https://doi.org/10.1016/S0140-6736(17)32253-5CrossRefPubMed

240.

Aune D, Giovannucci E, Boffetta P et al (2017) Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol 46:1029–1056. https://doi.org/10.1093/ije/dyw319CrossRefPubMedPubMedCentral

241.

Bechthold A, Boeing H, Schwedhelm C et al (2019) Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr 59:1071–1090. https://doi.org/10.1080/10408398.2017.1392288CrossRefPubMed

242.

Zhan J, Liu YJ, Cai LB et al (2017) Fruit and vegetable consumption and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 57:1650–1663. https://doi.org/10.1080/10408398.2015.1008980CrossRefPubMed

243.

Willett W, Rockström J, Loken B et al (2019) Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 393:447–492. https://doi.org/10.1016/S0140-6736(18)31788-4CrossRefPubMed

244.

Barnard ND, Cohen J, Jenkins DJA et al (2006) A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 29:1777–1783. https://doi.org/10.2337/dc06-0606CrossRefPubMed

245.

Jenkins DJA, Kendall CWC, Augustin LSA et al (2012) Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 172:1653–1660. https://doi.org/10.1001/2013.jamainternmed.70CrossRefPubMed

246.

Renner B, Arens-Azevêdo U, Watzl B et al (2021) DGE-Positionspapier zur nachhaltigeren Ernährung. ernährungsumschau 68:144–154

247.

Jannasch F, Kröger J, Schulze MB (2017) Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J Nutr 147:1174–1182. https://doi.org/10.3945/jn.116.242552CrossRefPubMed

248.

Wallin A, Di Giuseppe D, Orsini N et al (2012) Fish consumption, dietary long-chain n‑3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 35:918–929. https://doi.org/10.2337/dc11-1631CrossRefPubMedPubMedCentral

249.

Xun P, He K (2012) Fish Consumption and Incidence of Diabetes: meta-analysis of data from 438000 individuals in 12 independent prospective cohorts with an average 11-year follow-up. Diabetes Care 35:930–938. https://doi.org/10.2337/dc11-1869CrossRefPubMedPubMedCentral

250.

Schwingshackl L, Hoffmann G, Lampousi AM et al (2017) Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol 32:363–375. https://doi.org/10.1007/s10654-017-0246-yCrossRefPubMedPubMedCentral

251.

Muley A, Muley P, Shah M (2014) ALA, fatty fish or marine n‑3 fatty acids for preventing DM?: a systematic review and meta-analysis. Curr Diabetes Rev 10:158–165. https://doi.org/10.2174/1573399810666140515113137CrossRefPubMed

252.

Schlesinger S, Neuenschwander M, Schwedhelm C et al (2019) Food groups and risk of overweight, obesity, and weight gain: a systematic review and dose-response meta-analysis of prospective studies. Adv Nutr 10:205–218. https://doi.org/10.1093/advances/nmy092CrossRefPubMedPubMedCentral

253.

Micha R, Shulkin ML, Peñalvo JL et al (2017) Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS ONE 12:e175149. https://doi.org/10.1371/journal.pone.0175149CrossRefPubMedPubMedCentral

254.

Jayedi A, Shab-Bidar S, Eimeri S et al (2018) Fish consumption and risk of all-cause and cardiovascular mortality: a dose-response meta-analysis of prospective observational studies. Public Health Nutr 21:1297–1306. https://doi.org/10.1017/S1368980017003834CrossRefPubMed

255.

Abdelhamid AS, Brown TJ, Brainard JS et al (2018) Omega‑3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003177.pub4CrossRefPubMedPubMedCentral

256.

Hu Y, Hu FB, Manson JE (2019) Marine omega‑3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc 8:e13543. https://doi.org/10.1161/JAHA.119.013543CrossRefPubMedPubMedCentral

257.

Gao H, Geng T, Huang T et al (2017) Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis 16:131. https://doi.org/10.1186/s12944-017-0528-0CrossRefPubMedPubMedCentral

258.

Chen C, Yu X, Shao S (2015) Effects of omega‑3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: a meta-analysis. PLoS ONE 10:e139565. https://doi.org/10.1371/journal.pone.0139565CrossRefPubMedPubMedCentral

259.

DGE – Deutsche Gesellschaft für Ernährung. Vollwertig essen und trinken nach den 10 Regeln der DGE. https://www.dge.de/ernaehrungspraxis/vollwertige-ernaehrung/10-regeln-der-dge/ (Erstellt: 13. Juli 2021)

260.

Zeraatkar D, Han MA, Guyatt GH et al (2019) Red and processed meat consumption and risk for all-cause mortality and cardiometabolic outcomes: a systematic review and meta-analysis of cohort studies. Ann Intern Med 171:703–710. https://doi.org/10.7326/M19-0655CrossRefPubMed

261.

Davidson MH, Hunninghake D, Maki KC et al (1999) Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med 159:1331–1338. https://doi.org/10.1001/archinte.159.12.1331CrossRefPubMed

262.

Hunninghake DB, Maki KC, Kwiterovich PO et al (2000) Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia. J Am Coll Nutr 19:351–360. https://doi.org/10.1080/07315724.2000.10718931CrossRefPubMed

263.

Bergeron N, Chiu S, Williams PT et al (2019) Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial. Am J Clin Nutr 110:24–33. https://doi.org/10.1093/ajcn/nqz035CrossRefPubMedPubMedCentral

264.

Charlton K, Walton K, Batterham M et al (2016) Pork and chicken meals similarly impact on cognitive function and strength in community-living older adults: a pilot study. J Nutr Gerontol Geriatr 35:124–145. https://doi.org/10.1080/21551197.2016.1162259CrossRefPubMed

265.

Murphy KJ, Parker B, Dyer KA et al (2014) A comparison of regular consumption of fresh lean pork, beef and chicken on body composition: a randomized cross-over trial. Nutrients 6:682–696. https://doi.org/10.3390/nu6020682CrossRefPubMedPubMedCentral

266.

Murphy KJ, Thomson RL, Coates AM et al (2012) Effects of eating fresh lean pork on cardiometabolic health parameters. Nutrients 4:711–723. https://doi.org/10.3390/nu4070711CrossRefPubMedPubMedCentral

267.

Johnston BC, Zeraatkar D, Han MA et al (2019) Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the nutritional recommendations (NutriRECS) consortium. Ann Intern Med 171:756–764. https://doi.org/10.7326/M19-1621CrossRefPubMed

268.

Davis PA, Yokoyama W (2011) Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food 14:884–889. https://doi.org/10.1089/jmf.2010.0180CrossRefPubMed

269.

Akilen R, Tsiami A, Devendra D et al (2012) Cinnamon in glycaemic control: systematic review and meta analysis. Clin Nutr 31:609–615. https://doi.org/10.1016/j.clnu.2012.04.003CrossRefPubMed

270.

Leach MJ, Kumar S (2012) Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007170.pub2CrossRefPubMedPubMedCentral

271.

Allen RW, Schwartzman E, Baker WL et al (2013) Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11:452–459. https://doi.org/10.1370/afm.1517CrossRefPubMedPubMedCentral

272.

Costello RB, Dwyer JT, Saldanha L et al (2016) Do cinnamon supplements have a role in glycemic control in type 2 diabetes? A narrative review. J Acad Nutr Diet 116:1794–1802. https://doi.org/10.1016/j.jand.2016.07.015CrossRefPubMedPubMedCentral

273.

Sierra-Puente D, Abadi-Alfie S, Arakanchi-Altaled K et al (2019) Cinammon (Cinnamomum Spp.) and type 2 diabetes mellitus. CTNR 18:247–255. https://doi.org/10.37290/ctnr2641-452X.18:247-255CrossRef

274.

Chan CB, Hashemi Z, Subhan FB (2017) The impact of low and no-caloric sweeteners on glucose absorption, incretin secretion, and glucose tolerance. Appl Physiol Nutr Metab 42:793–801. https://doi.org/10.1139/apnm-2016-0705CrossRefPubMed

275.

Brown AW, Bohan Brown MM, Onken KL et al (2011) Short-term consumption of sucralose, a nonnutritive sweetener, is similar to water with regard to select markers of hunger signaling and short-term glucose homeostasis in women. Nutr Res 31:882–888. https://doi.org/10.1016/j.nutres.2011.10.004CrossRefPubMed

276.

Ford HE, Peters V, Martin NM et al (2011) Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects. Eur J Clin Nutr 65:508–513. https://doi.org/10.1038/ejcn.2010.291CrossRefPubMed

277.

Steinert RE, Frey F, Töpfer A et al (2011) Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr 105:1320–1328. https://doi.org/10.1017/S000711451000512XCrossRefPubMed

278.

Barriocanal LA, Palacios M, Benitez G et al (2008) Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol 51:37–41. https://doi.org/10.1016/j.yrtph.2008.02.006CrossRefPubMed

279.

Brown RJ, Walter M, Rother KI (2012) Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care 35:959–964. https://doi.org/10.2337/dc11-2424CrossRefPubMedPubMedCentral

280.

Grotz VL, Henry RR, McGill JB et al (2003) Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 103:1607–1612. https://doi.org/10.1016/j.jada.2003.09.021CrossRefPubMed

281.

Maki KC, Curry LL, Reeves MS et al (2008) Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 46(Suppl. 07):S47–S53. https://doi.org/10.1016/j.fct.2008.05.007CrossRefPubMed

282.

Olalde-Mendoza L, Moreno-González YE (2013) Modificación de la glucemia en ayuno en adultos con diabetes mellitus tipo 2 después de la ingesta de refrescos de cola y de dieta en el estado de querétaro, México. Arch Latinoam Nutr 63:142–147PubMed

283.

Temizkan S, Deyneli O, Yasar M et al (2015) Sucralose enhances GLP‑1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes. Eur J Clin Nutr 69:162–166. https://doi.org/10.1038/ejcn.2014.208CrossRefPubMed

284.

Ferrazzano GF, Cantile T, Alcidi B et al (2015) Is Stevia rebaudiana Bertoni a non Cariogenic sweetener? A review. Molecules 21:E38. https://doi.org/10.3390/molecules21010038CrossRefPubMed

285.

Prashant GM, Patil RB, Nagaraj T et al (2012) The antimicrobial activity of the three commercially available intense sweeteners against common periodontal pathogens: an in vitro study. J Contemp Dent Pract 13:749–752. https://doi.org/10.5005/jp-journals-10024-1222CrossRefPubMed

286.

Suez J, Korem T, Zeevi D et al (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514:181–186. https://doi.org/10.1038/nature13793CrossRefPubMed

287.

EFSA (2013) EFSA schließt vollständige Risikobewertung zu Aspartam ab und kommt zu dem Schluss, dass es in den derzeitigen Expositionsmengen sicher ist. https://www.efsa.europa.eu/de/press/news/131210 (Erstellt: 1. Sept. 2020)

288.

Bundesinstitut für Risikobewertung Bewertung von Süßstoffen und Zuckeraustauschstoffen. Hintergrundinformation Nr. 025/2014 des BfR vom 1. Juli 2014. www.bfr.bund.de/cm/343/bewertung_von_suessstoffen.pdf (Erstellt: 1. Sept. 2020)

289.

Bock PM, Telo GH, Ramalho R et al (2021) The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 64:26–41. https://doi.org/10.1007/s00125-020-05295-1CrossRefPubMed

290.

Rittiphairoj T, Pongpirul K, Janchot K et al (2021) Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Adv Nutr 12:722–734. https://doi.org/10.1093/advances/nmaa133CrossRefPubMed

291.

Tao YW, Gu YL, Mao XQ et al (2020) Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med 18:30. https://doi.org/10.1186/s12967-020-02213-2CrossRefPubMedPubMedCentral

292.

Ardeshirlarijani E, Tabatabaei-Malazy O, Mohseni S et al (2019) Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials. Daru 27:827–837. https://doi.org/10.1007/s40199-019-00302-2CrossRefPubMedPubMedCentral

293.

Mahboobi S, Rahimi F, Jafarnejad S (2018) Effects of prebiotic and Synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: a meta-analysis of randomized controlled trials. Adv Pharm Bull 8:565–574. https://doi.org/10.15171/apb.2018.065CrossRefPubMedPubMedCentral

294.

Akbari V, Hendijani F (2016) Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev 74:774–784. https://doi.org/10.1093/nutrit/nuw039CrossRefPubMed

295.

Yao K, Zeng L, He Q et al (2017) Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monit 23:3044–3053. https://doi.org/10.12659/msm.902600CrossRefPubMedPubMedCentral

296.

Wang C, Zhang C, Li S et al (2020) Effects of probiotic supplementation on dyslipidemia in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Foods. https://doi.org/10.3390/foods9111540CrossRefPubMedPubMedCentral

297.

Kasińska MA, Drzewoski J (2015) Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn 125:803–813. https://doi.org/10.20452/pamw.3156CrossRefPubMed

298.

Palacios T, Vitetta L, Coulson S et al (2020) Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: a randomised controlled pilot study. Nutrients. https://doi.org/10.3390/nu12072041CrossRefPubMedPubMedCentral

299.

Zheng M, Zhang R, Tian X et al (2017) Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Front Microbiol 8:908. https://doi.org/10.3389/fmicb.2017.00908CrossRefPubMedPubMedCentral

300.

Wong A, Ngu DYS, Dan LA et al (2015) Detection of antibiotic resistance in probiotics of dietary supplements. Nutr J 14:95. https://doi.org/10.1186/s12937-015-0084-2CrossRefPubMedPubMedCentral

301.

BgVV – ehemals: Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin Abschlussbericht der Arbeitsgruppe „Probiotische Mikroorganismenkulturen in Lebensmitteln“ am BgVV. https://mobil.bfr.bund.de/cm/343/probiot.pdf (Erstellt: 13. Juli 2021)

302.

de Vrese M (2008) Mikrobiologie, Wirkung und Sicherheit von Probiotika. Monatsschr Kinderheilkd 156:1063–1069. https://doi.org/10.1007/s00112-008-1829-1CrossRef

303.

Vrieze A, van Nood E, Holleman F et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:913–916.e7. https://doi.org/10.1053/j.gastro.2012.06.031CrossRefPubMed

304.

Simon MC, Strassburger K, Nowotny B et al (2015) Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 38:1827–1834. https://doi.org/10.2337/dc14-2690CrossRefPubMed

305.

Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63:1513–1521. https://doi.org/10.1136/gutjnl-2014-306928CrossRefPubMed

306.

Kjems LL, Holst JJ, Vølund A et al (2003) The influence of GLP‑1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380–386. https://doi.org/10.2337/diabetes.52.2.380CrossRefPubMed

307.

Karlsson FH, Tremaroli V, Nookaew I et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103. https://doi.org/10.1038/nature12198CrossRefPubMed

308.

Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60. https://doi.org/10.1038/nature11450CrossRefPubMed

309.

Larsen N, Vogensen FK, van den Berg FWJ et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085. https://doi.org/10.1371/journal.pone.0009085CrossRefPubMedPubMedCentral

310.

Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858. https://doi.org/10.1038/nm.4345CrossRefPubMed

311.

Forslund K, Hildebrand F, Nielsen T et al (2017) Corrigendum: disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 545:116. https://doi.org/10.1038/nature22318CrossRefPubMed

312.

Forslund K, Hildebrand F, Nielsen T et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266. https://doi.org/10.1038/nature15766CrossRefPubMedPubMedCentral

313.

Caesar R (2019) Pharmacologic and nonpharmacologic therapies for the gut microbiota in type 2 diabetes. Can J Diabetes 43:224–231. https://doi.org/10.1016/j.jcjd.2019.01.007CrossRefPubMed

314.

Evert AB, Boucher JL, Cypress M et al (2014) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37(Suppl. 01):S120–S143. https://doi.org/10.2337/dc14-S120CrossRefPubMed

315.

Sievenpiper JL, Chan CB, Dworatzek PD et al (2018) Nutrition therapy. Can J Diabetes 42(Suppl. 01):S64–S79. https://doi.org/10.1016/j.jcjd.2017.10.009CrossRefPubMed

316.

Sievenpiper JL, de Souza RJ, Mirrahimi A et al (2012) Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 156:291–304. https://doi.org/10.7326/0003-4819-156-4-201202210-00007CrossRefPubMed

317.

Ha V, Sievenpiper JL, de Souza RJ et al (2012) Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 59:787–795. https://doi.org/10.1161/HYPERTENSIONAHA.111.182311CrossRefPubMed

318.

Chiavaroli L, de Souza RJ, Ha V et al (2015) Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc 4:e1700. https://doi.org/10.1161/JAHA.114.001700CrossRefPubMedPubMedCentral

319.

Wang X, Ouyang Y, Liu J et al (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349:g4490. https://doi.org/10.1136/bmj.g4490CrossRefPubMedPubMedCentral

320.

Chiu S, Sievenpiper JL, de Souza RJ et al (2014) Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 68:416–423. https://doi.org/10.1038/ejcn.2014.8CrossRefPubMedPubMedCentral

321.

Wang DD, Sievenpiper JL, de Souza RJ et al (2012) The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 142:916–923. https://doi.org/10.3945/jn.111.151951CrossRefPubMedPubMedCentral

322.

Cozma AI, Sievenpiper JL, de Souza RJ et al (2012) Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care 35:1611–1620. https://doi.org/10.2337/dc12-0073CrossRefPubMedPubMedCentral

323.

Sievenpiper JL, Chiavaroli L, de Souza RJ et al (2012) ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr 108:418–423. https://doi.org/10.1017/S000711451200013XCrossRefPubMedPubMedCentral

324.

Sievenpiper JL, Carleton AJ, Chatha S et al (2009) Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 32:1930–1937. https://doi.org/10.2337/dc09-0619CrossRefPubMedPubMedCentral

325.

Chung M, Ma J, Patel K et al (2014) Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 100:833–849. https://doi.org/10.3945/ajcn.114.086314CrossRefPubMedPubMedCentral

326.

Goran MI, Ulijaszek SJ, Ventura EE (2013) High fructose corn syrup and diabetes prevalence: a global perspective. Glob Public Health 8:55–64. https://doi.org/10.1080/17441692.2012.736257CrossRefPubMed

327.

Tsilas CS, de Souza RJ, Mejia SB et al (2017) Relation of total sugars, fructose and sucrose with incident type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Cmaj 189:E711–E720. https://doi.org/10.1503/cmaj.160706CrossRefPubMedPubMedCentral

328.

Wang DD, Sievenpiper JL, de Souza RJ et al (2014) Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 232:125–133. https://doi.org/10.1016/j.atherosclerosis.2013.10.019CrossRef

329.

Zhang YH, An T, Zhang RC et al (2013) Very high fructose intake increases serum LDL-cholesterol and total cholesterol: a meta-analysis of controlled feeding trials. J Nutr 143:1391–1398. https://doi.org/10.3945/jn.113.175323CrossRefPubMed

330.

Schwingshackl L, Neuenschwander M, Hoffmann G et al (2020) Dietary sugars and cardiometabolic risk factors: a network meta-analysis on isocaloric substitution interventions. Am J Clin Nutr 111:187–196. https://doi.org/10.1093/ajcn/nqz273CrossRefPubMed

331.

Weber KS, Simon MC, Strassburger K et al (2018) Habitual fructose intake relates to insulin sensitivity and fatty liver index in recent-onset type 2 diabetes patients and individuals without diabetes. Nutrients. https://doi.org/10.3390/nu10060774CrossRefPubMedPubMedCentral

332.

ter Horst KW, Schene MR, Holman R et al (2016) Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr 104:1562–1576. https://doi.org/10.3945/ajcn.116.137786CrossRefPubMed

333.

Kulzer B, Albus C, Herpertz S et al (2019) Psychosoziales und Diabetes. Diabetologe 15:452–469. https://doi.org/10.1007/s11428-018-0440-xCrossRef

334.

Ahmed AT, Karter AJ, Warton EM et al (2008) The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 23:275–282. https://doi.org/10.1007/s11606-007-0502-zCrossRefPubMedPubMedCentral

335.

Bantle AE, Thomas W, Bantle JP (2008) Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism 57:241–245. https://doi.org/10.1016/j.metabol.2007.09.007CrossRefPubMedPubMedCentral

336.

Avogaro A, Beltramello P, Gnudi L et al (1993) Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids. Diabetes 42:1626–1634CrossRef

337.

Turner BC, Jenkins E, Kerr D et al (2001) The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 24:1888–1893. https://doi.org/10.2337/diacare.24.11.1888CrossRefPubMed

338.

Richardson T, Weiss M, Thomas P et al (2005) Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 28:1801–1802. https://doi.org/10.2337/diacare.28.7.1801CrossRefPubMed

339.

Pedersen-Bjergaard U, Reubsaet JLE, Nielsen SL et al (2005) Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: analysis of 141 cases. Am J Med 118:307–310. https://doi.org/10.1016/j.amjmed.2004.07.054CrossRefPubMed

340.

Frier B, Fisher M (Hrsg) (2007) Moderators, monitoring and management of hypoglycaemia [101–120]. John Wiley & Sons, Chichester

341.

Ahmed AT, Karter AJ, Liu J (2006) Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabetic Med 23:795–802. https://doi.org/10.1111/j.1464-5491.2006.01878.xCrossRefPubMed

342.

Nahas R, Goguen J (2013) Natural health products. Can J Diabetes 37(Suppl. 01):S97–S99. https://doi.org/10.1016/j.jcjd.2013.01.029CrossRefPubMed

343.

Hartweg J, Perera R, Montori V et al (2008) Omega‑3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003205.pub2CrossRefPubMedPubMedCentral

344.

Hartweg J, Farmer AJ, Holman RR et al (2009) Potenzial impact of omega‑3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 20:30–38. https://doi.org/10.1097/mol.0b013e328321b3beCrossRefPubMed

345.

O’Mahoney LL, Matu J, Price OJ et al (2018) Omega‑3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 17:98. https://doi.org/10.1186/s12933-018-0740-xCrossRefPubMedPubMedCentral

346.

Mirhosseini N, Vatanparast H, Mazidi M et al (2017) The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: a meta-analysis. J Clin Endocrinol Metab 102:3097–3110. https://doi.org/10.1210/jc.2017-01024CrossRefPubMed

347.

Li X, Liu Y, Zheng Y et al (2018) The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/nu10030375CrossRefPubMedPubMedCentral

348.

Jafari T, Fallah AA, Barani A (2016) Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Clin Nutr 35:1259–1268. https://doi.org/10.1016/j.clnu.2016.03.001CrossRefPubMed

349.

Mousa A, Naderpoor N, Teede H et al (2018) Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 76:380–394. https://doi.org/10.1093/nutrit/nux077CrossRefPubMed

350.

Lee KJ, Lee YJ (2016) Effects of vitamin D on blood pressure in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 54:233–242. https://doi.org/10.5414/CP202493CrossRefPubMed

351.

Yu Y, Tian L, Xiao Y et al (2018) Effect of vitamin D supplementation on some inflammatory biomarkers in type 2 diabetes mellitus subjects: a systematic review and meta-analysis of randomized controlled trials. Ann Nutr Metab 73:62–73. https://doi.org/10.1159/000490358CrossRefPubMed

352.

Verma H, Garg R (2017) Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 30:621–633. https://doi.org/10.1111/jhn.12454CrossRefPubMed

353.

Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M et al (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272–282. https://doi.org/10.1016/j.phrs.2016.06.019CrossRefPubMed

354.

Asbaghi O, Hosseini R, Boozari B et al (2021) The effects of magnesium supplementation on blood pressure and obesity measure among type 2 diabetes patient: a systematic review and meta-analysis of randomized controlled trials. Biol Trace Elem Res 199:413–424. https://doi.org/10.1007/s12011-020-02157-0CrossRefPubMed

355.

Vincent JB (2000) Elucidating a biological role for chromium at a molecular level. Acc Chem Res 33:503–510. https://doi.org/10.1021/ar990073rCrossRefPubMed

356.

Asbaghi O, Fatemeh N, Mahnaz RK et al (2020) Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 161:105098. https://doi.org/10.1016/j.phrs.2020.105098CrossRefPubMed

357.

Yin RV, Phung OJ (2015) Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutr J 14:14. https://doi.org/10.1186/1475-2891-14-14CrossRefPubMedPubMedCentral

358.

Suksomboon N, Poolsup N, Yuwanakorn A (2014) Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther 39:292–306. https://doi.org/10.1111/jcpt.12147CrossRefPubMed

359.

Chimienti F (2013) Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 26:1–11. https://doi.org/10.1017/S0954422412000212CrossRefPubMed

360.

de Carvalho GB (2017) Zinc’s role in the glycemic control of patients with type 2 diabetes: a systematic review. Biometals. https://doi.org/10.1007/s10534-017-9996-yCrossRefPubMed

361.

Fernández-Cao JC, Warthon-Medina M, Hall MV et al (2018) Dietary zinc intake and whole blood zinc concentration in subjects with type 2 diabetes versus healthy subjects: A systematic review, meta-analysis and meta-regression. J Trace Elem Med Biol 49:241–251. https://doi.org/10.1016/j.jtemb.2018.02.008CrossRefPubMed

362.

Wang X, Wu W, Zheng W et al (2019) Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 110:76–90. https://doi.org/10.1093/ajcn/nqz041CrossRefPubMed

363.

Asbaghi O, Sadeghian M, Fouladvand F et al (2020) Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 30:1260–1271. https://doi.org/10.1016/j.numecd.2020.03.021CrossRefPubMed

364.

Rahimi R, Nikfar S, Larijani B et al (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365–373. https://doi.org/10.1016/j.biopha.2005.07.002CrossRefPubMed

365.

Ashor AW, Werner AD, Lara J et al (2017) Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr 71:1371–1380. https://doi.org/10.1038/ejcn.2017.24CrossRefPubMed

366.

Xu R, Zhang S, Tao A et al (2014) Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials. Plos One 9:e95008. https://doi.org/10.1371/journal.pone.0095008CrossRefPubMedPubMedCentral

367.

Khodaeian M, Tabatabaei-Malazy O, Qorbani M et al (2015) Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study. Eur J Clin Invest 45:1161–1174. https://doi.org/10.1111/eci.12534CrossRefPubMed

368.

Montero D, Walther G, Stehouwer CDA et al (2014) Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15:107–116. https://doi.org/10.1111/obr.12114CrossRefPubMed

369.

Tabatabaei-Malazy O, Ardeshirlarijani E, Namazi N et al (2019) Dietary antioxidative supplements and diabetic retinopathy; a systematic review. J Diabetes Metab Disord 18:705–716. https://doi.org/10.1007/s40200-019-00434-xCrossRefPubMedPubMedCentral

370.

Jeyaraman MM, Al-Yousif NSH, Singh Mann A et al (2020) Resveratrol for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011919.pub2CrossRefPubMedPubMedCentral

371.

Palma-Duran SA, Vlassopoulos A, Lean M et al (2017) Nutritional intervention and impact of polyphenol on glycohemoglobin (HbA1c) in non-diabetic and type 2 diabetic subjects: Systematic review and meta-analysis. Crit Rev Food Sci Nutr 57:975–986. https://doi.org/10.1080/10408398.2014.973932CrossRefPubMed

372.

Fogacci F, Tocci G, Presta V et al (2019) Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr 59:1605–1618. https://doi.org/10.1080/10408398.2017.1422480CrossRefPubMed

373.

Drzikova B (2005) Haferprodukte mit modifiziertem Gehalt an β‑Glucanen und resistenter Stärke und ihre Effekte auf den Gastrointestinaltrakt unter In-vitro- und In-vivo-Bedingungen. http://opus.kobv.de/ubp/volltexte/205/592/

374.

He L, Zhao J, Huang Y et al (2016) The difference between oats and beta-glucan extract intake in the management of HbA1c, fasting glucose and insulin sensitivity: a meta-analysis of randomized controlled trials. Food Funct 7:1413–1428. https://doi.org/10.1039/c5fo01364jCrossRefPubMed

375.

Abbasi NN, Purslow PP, Tosh SM et al (2016) Oat β‑glucan depresses SGLT1- and GLUT2-mediated glucose transport in intestinal epithelial cells (IEC-6). Nutr Res 36:541–552. https://doi.org/10.1016/j.nutres.2016.02.004CrossRefPubMed

376.

Wang F, Yu G, Zhang Y et al (2015) Dipeptidyl peptidase IV inhibitory peptides derived from oat (Avena sativa L.), buckwheat (Fagopyrum esculentum), and highland barley (Hordeum vulgare trifurcatum (L.) Trofim) proteins. J Agric Food Chem 63:9543–9549. https://doi.org/10.1021/acs.jafc.5b04016CrossRefPubMed

377.

Liu M, Zhang Y, Zhang H et al (2016) The anti-diabetic activity of oat β‑d-glucan in streptozotocin-nicotinamide induced diabetic mice. Int J Biol Macromol 91:1170–1176. https://doi.org/10.1016/j.ijbiomac.2016.06.083CrossRefPubMed

378.

Lammert A, Kratzsch J, Selhorst J et al (2008) Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study. Exp Clin Endocrinol Diabetes 116:132–134. https://doi.org/10.1055/s-2007-984456CrossRefPubMed

379.

Delgado G, Kleber ME, Krämer BK et al (2019) Dietary intervention with oatmeal in patients with uncontrolled type 2 diabetes mellitus—a crossover study. Exp Clin Endocrinol Diabetes 127:623–629. https://doi.org/10.1055/a-0677-6068CrossRefPubMed

380.

Delgado GE, Krämer BK, Scharnagl H et al (2020) Bile acids in patients with uncontrolled type 2 diabetes mellitus—the effect of two days of oatmeal treatment. Exp Clin Endocrinol Diabetes 128:624–630. https://doi.org/10.1055/a-1069-7330CrossRefPubMed

381.

Behall KM, Scholfield DJ, Hallfrisch J (2005) Comparison of hormone and glucose responses of overweight women to barley and oats. J Am Coll Nutr 24:182–188. https://doi.org/10.1080/07315724.2005.10719464CrossRefPubMed

382.

Braaten JT, Scott FW, Wood PJ et al (1994) High beta–glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 11:312–318. https://doi.org/10.1111/j.1464-5491.1994.tb00277.xCrossRefPubMed

383.

Pick ME, Hawrysh ZJ, Gee MI et al (1996) Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96:1254–1261. https://doi.org/10.1016/S0002-8223(96)00329-XCrossRefPubMed

384.

Tapola N, Karvonen H, Niskanen L et al (2005) Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 15:255–261. https://doi.org/10.1016/j.numecd.2004.09.003CrossRefPubMed

385.

Tappy L, Gügolz E, Würsch P (1996) Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19:831–834. https://doi.org/10.2337/diacare.19.8.831CrossRefPubMed

386.

Wood PJ, Beer MU, Butler G (2000) Evaluation of role of concentration and molecular weight of oat beta-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load. Br J Nutr 84:19–23CrossRef

387.

[Anonym]. Scientific Opinion on the substantiation of health claims related to beta glucans and maintenance or achievement of normal blood glucose concentrations (ID 756, 802, 2935) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFS2 2010; 8 https://doi.org/10.2903/j.efsa.2010.1482

388.

Amtsblatt der Europäischen Union 2011 L 136/1 vom 25. Mai 2012. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:136:0001:0040:DE:PDF ; Stand: 4. Juli 2021

389.

Zurbau A, Noronha JC, Khan TA et al (2021) The effect of oat β‑glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. Eur J Clin Nutr. https://doi.org/10.1038/s41430-021-00875-9CrossRefPubMedPubMedCentral

390.

Battilana P, Ornstein K, Minehira K et al (2001) Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 55:327–333. https://doi.org/10.1038/sj.ejcn.1601160CrossRefPubMed

391.

Jenkins AL, Jenkins DJA, Zdravkovic U et al (2002) Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr 56:622–628. https://doi.org/10.1038/sj.ejcn.1601367CrossRefPubMed

Springer Medizin

Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 2

Auszug

Passend zum Thema

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Vitamin-B12-Mangel durch Arzneimittel

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Laktatspiegel und Hypoglykämiewahrnehmung bei Typ-1-Diabetes

Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 1

Erratum zu: Gestationsdiabetes mellitus – Teil 1: Screening und Diagnostik

DDG Praxisempfehlungen: Lipidtherapie bei Patienten mit Diabetes mellitus

Moderne endovaskuläre Therapieoptionen bei diabetischem Fußsyndrom

Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz

Passend zum Thema

Fatal verkannt: Vitamin-B12-Mangel frühzeitig behandeln!

Vitamin-B12-Mangel durch Arzneimittel

Vitamin-B12-Mangel – Aktuelles Basiswissen für die Praxis.